ANGELMAN SYNDROME
Clinical trials for ANGELMAN SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANGELMAN SYNDROME trials appear
Sign up with your email to follow new studies for ANGELMAN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New angelman drug shows promise in early safety trial
Disease control CompletedThis study tested a new medicine called GTX-102 in 74 children with Angelman Syndrome, a rare genetic disorder causing developmental delays and seizures. The main goal was to see if the drug is safe and tolerable when given as a spinal injection. Researchers monitored side effect…
Matched conditions: ANGELMAN SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug trial hopes to ease angelman syndrome symptoms in kids
Disease control CompletedThis study tested a drug called alogabat in 48 children aged 5-17 with Angelman syndrome (a specific genetic type). The goal was to see how the drug moves through the body and if it is safe. Researchers also looked at brain activity changes to see if the drug works as expected. T…
Matched conditions: ANGELMAN SYNDROME
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New registry aims to shed light on angelman syndrome
Knowledge-focused CompletedThis completed registry study collected information from 82 people with Angelman syndrome in Italy. The goal was to track medical and behavioral problems linked to the condition. No treatments or interventions were tested; instead, the data will help researchers better understand…
Matched conditions: ANGELMAN SYNDROME
Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC